News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Médico atendiendo a un paciente en una consulta
ORYZON announces first patient dosed in NCI-sponsored iadademstat in combination with venetoclax and azacitidine clinical trial in first line acute myeloid leukemia
Healthcare · Innovative drugs
Study conducted under the CRADA agreement between NCI and Oryzon.
Partners - Oryzon Genomics
Imagen de un cerebro relacionada con la investigación del Alzhéimer en España
BCN HEALTH publishes a study assessing the epidemiological situation and cost of Alzheimer's disease in Spain
Healthcare
The medical costs of Alzheimer's disease in hospital care increased during the study period, with…
Partners - BCN Health
Guillermo Rodriguez Lázaro, Director Científico de Grupo AIA
#NewAseBioMember | “AseBio is a key player in the growth of biotechnology in Spain”
Corporate
Meet Grupo AIA, our new member. We spoke with Guillermo Rodriguez Lázaro, Chief…
AseBio - Aplicaciones en Informática Avanzada
sede oryzon
ORYZON to provide corporate progress updates at several events in January-February
Corporate
Among these, the following stand out 8º Sachs Annual Neuroscience Innovation Forum, 14º Annual…
Partners - Oryzon Genomics
Laboratorio de Viva in Vitro
Key Trends in Sepsis for 2025
Healthcare · Personalized medicine · Advanced therapies
In Spain, the incidence of sepsis is 212 cases per 100,000 inhabitants per year, with a mortality…
Partners - VIVA IN VITRO
Equipo IQS
New Approach to Glycovaccines
Healthcare · Access to innovation · Innovative drugs
IQS researchers are designing a new generation of glyconanoparticles functionalized with α-mannose…
Partners - IQS
Report Antibody Drug Conjugates Market of Alira Health
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market
Healthcare · Access to innovation · Drug discovery
Analysis projects 21% annual growth, with global sales expected to reach $39 billion by 2030.
Partners - Alira Health
Samuel Sánchez, cofundador de Nanobots Therapeutics
Nanobots Therapeutics advances its development after securing the first million in its seed round
Healthcare · Innovative drugs · Personalized medicine · Financing
The startup successfully completed the first stage of its seed investment round, raising €960,000…
Partners - NANOBOTS THERAPEUTICS
Logo Theriva
Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer
Healthcare · Innovative drugs
Partners - THERIVA BIOLOGICS S.L.